Elsevier

European Journal of Cancer

Volume 31, Issues 7–8, July–August 1995, Pages 1306-1310
European Journal of Cancer

Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: Preliminary report from an ongoing trial

https://doi.org/10.1016/0959-8049(95)00326-EGet rights and content

Abstract

A clinical trial for patients with measurable, disseminated colorectal cancer is being conducted to determine: (1) if intratumoral expression of thymidylate synthase (TS) affects response to protracted-infusion 5-fluorouracil (5FU); and (2) whether intratumoral expression of TS increases when clinical resistance is found after response to 5-FU. Polymerase chain reaction technology is employed to determine TS expression. Using β-actin as an internal standard, TS expressions for 26 patients range from 0.5 × 10−3 to 22.6 × 103̄. Currently, 22 patients are evaluable for response and TS quantitation of their measurable tumour. 8 patients (36%) have had partial responses; 3 responding patients had been previously treated with 5-FU. A strong statistical association between TS expression and resistance to therapy has been found (P = 0.004). No patient with TS expression of 4.0 × 10−3 or greater has responded. On average, patients previously treated with 5-FU have slightly higher levels of TS expression in their measurable tumours (P = 0.4). Whether responding patients will develop increased expressions of TS upon clinical progression of their cancer remains to be determined. Confirmation of these results in a larger cohort could lead to a scientific rationale for deciding upon specific therapy for patients with disseminated colorectal cancers.

References (28)

  • WL Washtien

    Thymidylate synthase levels as a factor in 5-fluorodeoxyuridine and methotrexate cytotoxicity in gastrointestinal tumor cells

    Mol Pharmac

    (1982)
  • SH Berger et al.

    Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells

    Mol Pharmac

    (1985)
  • SM Swain et al.

    Fluorouracil and high dose leucovorin in previously treated patients with metastatic breast cancer

    J Clin Oncol

    (1989)
  • E Chu et al.

    Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines

    Mol Pharmac

    (1990)
  • Cited by (0)

    View full text